Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance

被引:116
|
作者
Laakso, M [1 ]
Lehto, S [1 ]
机构
[1] Univ Kuopio, Dept Med, FIN-70211 Kuopio, Finland
关键词
non-insulin-dependent diabetes; coronary heart disease; cerebrovascular disease; peripheral vascular disease;
D O I
10.1016/S0021-9150(97)00314-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetes mellitus is a strong risk factor for all manifestations of atherosclerotic vascular disease, coronary heart disease (CHD), cerebrovascular disease and peripheral vascular disease. Diabetes can be classified into two main subtypes, insulin-dependent diabetes mellitus and non-insulin-dependent diabetes mellitus (NIDDM). This review focuses only on NIDDM. Also, in impaired glucose tolerance (IGT), a precursor stage of diabetes, the risk of macrovascular disease is substantially increased. NIDDM and IGT are known to be associated with several adverse cardiovascular risk factors, including hypertension, obesity, central obesity, hyperinsulinemia and serum lipid and lipoprotein abnormalities, characterized mainly by elevated serum total triglycerides and low high-density lipoprotein cholesterol. Practically no information is available on the role of different cardiovascular risk factors to predict macrovascular complications in subjects with IGT. The role of different cardiovascular risk factors with respect to the risk of CHD, stroke and peripheral vascular disease will be discussed. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:S65 / S73
页数:9
相关论文
共 50 条
  • [21] Epidemiology of Cardiovascular Risk Factors in Asian Countries
    Nguyen, Ho N.
    Fujiyoshi, Akira
    Abbott, Robert D.
    Miura, Katsuyuki
    CIRCULATION JOURNAL, 2013, 77 (12) : 2851 - 2859
  • [22] Diabetes and cardiovascular disease: inter-relation of risk factors and treatment
    Sharma, Aman
    Mittal, Shweta
    Aggarwal, Rohan
    Chauhan, Meenakshi K.
    FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 6 (01)
  • [23] Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention
    Wong, Nathan D.
    Sattar, Naveed
    NATURE REVIEWS CARDIOLOGY, 2023, 20 (10) : 685 - 695
  • [24] Cardiovascular disease in type 2 diabetes Attributable risk due to modifiable risk factors
    Zeber, John
    Parchman, Michael L.
    CANADIAN FAMILY PHYSICIAN, 2010, 56 (08) : E302 - E307
  • [25] Randomised controlled trial evaluating the effectiveness of behavioural interventions to modify cardiovascular risk factors in men and women with impaired glucose tolerance: outcomes at 6 months
    Oldroyd, JC
    Unwin, NC
    White, M
    Imrie, K
    Mathers, JC
    Alberti, KGMM
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2001, 52 (01) : 29 - 43
  • [26] Diabetes in Asia Epidemiology, Risk Factors, and Pathophysiology
    Chan, Juliana C. N.
    Malik, Vasanti
    Jia, Weiping
    Kadowaki, Takashi
    Yajnik, Chittaranjan S.
    Yoon, Kun-Ho
    Hu, Frank B.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (20): : 2129 - 2140
  • [27] The Evolving Epidemiology of Atherosclerotic Cardiovascular Disease in People with Diabetes
    Pasquel, Francisco J.
    Gregg, Edward W.
    Ali, Mohammed K.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2018, 47 (01) : 1 - 32
  • [28] Risk factors differ by first manifestation of cardiovascular disease in type 1 diabetes
    Miller, Rachel G.
    Orchard, Trevor J.
    Costacou, Tina
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 163
  • [29] Ethnic Disparities in the Risk Factors, Morbidity, and Mortality of Cardiovascular Disease in People With Diabetes
    Nair, Lekshmi
    Asuzu, Peace
    Dagogo-Jack, Sam
    JOURNAL OF THE ENDOCRINE SOCIETY, 2024, 8 (07)
  • [30] Familial predisposition to cardiovascular risk and disease contributes to cardiovascular risk and disease interacting with other cardiovascular risk factors in diabetes-Implication for common soil (JDDM 14)
    Yokoyama, Hiroki
    Kawai, Koichi
    Ohishi, Mariko
    Sone, Hirohito
    ATHEROSCLEROSIS, 2008, 201 (02) : 332 - 338